Novel Clinical Target in Fragile X Syndrome
Condition: Fragile X Syndrome (FXS) Intervention: Drug: 18F-FTC-146 Sponsor: Stanford University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Fragile X Syndrome | Research